Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11589698
[patent_doc_number] => 20170114109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN TARGET'
[patent_app_type] => utility
[patent_app_number] => 15/380168
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 29428
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380168 | Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target | Dec 14, 2016 | Issued |
Array
(
[id] => 17635209
[patent_doc_number] => 11345926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Transposon system, kit comprising the same, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/766707
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6361
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766707 | Transposon system, kit comprising the same, and uses thereof | Dec 11, 2016 | Issued |
Array
(
[id] => 12425154
[patent_doc_number] => 09974889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Gene delivery stent using titanium oxide thin film coating and method for fabricating the same
[patent_app_type] => utility
[patent_app_number] => 15/368825
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7988
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368825 | Gene delivery stent using titanium oxide thin film coating and method for fabricating the same | Dec 4, 2016 | Issued |
Array
(
[id] => 11866499
[patent_doc_number] => 20170233783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'REAGENT CARTRIDGE AND METHODS FOR DETECTION OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/365271
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32956
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365271 | Reagent cartridge and methods for detection of cells | Nov 29, 2016 | Issued |
Array
(
[id] => 13552471
[patent_doc_number] => 20180327783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => TRANSDUCTION BUFFER
[patent_app_type] => utility
[patent_app_number] => 15/775791
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775791
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775791 | TRANSDUCTION BUFFER | Nov 29, 2016 | Pending |
Array
(
[id] => 13584667
[patent_doc_number] => 20180343882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => SUPPLEMENTATION OF MILK FORMULAS WITH MICROVESICLES ISOLATED FROM MILK
[patent_app_type] => utility
[patent_app_number] => 15/778993
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778993 | Supplementation of milk formulas with microvesicles isolated from milk | Nov 28, 2016 | Issued |
Array
(
[id] => 14169375
[patent_doc_number] => 10258674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same
[patent_app_type] => utility
[patent_app_number] => 15/362196
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 57
[patent_no_of_words] => 13307
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362196
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/362196 | Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same | Nov 27, 2016 | Issued |
Array
(
[id] => 18800027
[patent_doc_number] => 11833172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration
[patent_app_type] => utility
[patent_app_number] => 15/779123
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 71
[patent_no_of_words] => 14258
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779123 | Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration | Nov 22, 2016 | Issued |
Array
(
[id] => 13151397
[patent_doc_number] => 10092399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Methods of conditioning sheet bioprosthetic tissue
[patent_app_type] => utility
[patent_app_number] => 15/357990
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 25
[patent_no_of_words] => 10054
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357990
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357990 | Methods of conditioning sheet bioprosthetic tissue | Nov 20, 2016 | Issued |
Array
(
[id] => 11497926
[patent_doc_number] => 20170072111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'SKIN PRINTING AND AUTO-GRAFTING'
[patent_app_type] => utility
[patent_app_number] => 15/352027
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6250
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352027 | SKIN PRINTING AND AUTO-GRAFTING | Nov 14, 2016 | Abandoned |
Array
(
[id] => 13289609
[patent_doc_number] => 10155985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Evaluation of eosinophilic esophagitis
[patent_app_type] => utility
[patent_app_number] => 15/340282
[patent_app_country] => US
[patent_app_date] => 2016-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 22232
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15340282
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/340282 | Evaluation of eosinophilic esophagitis | Oct 31, 2016 | Issued |
Array
(
[id] => 15306563
[patent_doc_number] => 10517963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Gene delivery system using polymer network
[patent_app_type] => utility
[patent_app_number] => 15/337252
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 4492
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337252 | Gene delivery system using polymer network | Oct 27, 2016 | Issued |
Array
(
[id] => 11441805
[patent_doc_number] => 20170042825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 15/335858
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24980
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335858
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335858 | LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM | Oct 26, 2016 | Abandoned |
Array
(
[id] => 11434920
[patent_doc_number] => 20170035941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Mineralization and Biological Modification of Biomaterial Surfaces'
[patent_app_type] => utility
[patent_app_number] => 15/333935
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17047
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15333935
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/333935 | Mineralization and Biological Modification of Biomaterial Surfaces | Oct 24, 2016 | Abandoned |
Array
(
[id] => 11604154
[patent_doc_number] => 20170121454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'ENZYMATIC SYNTHESIS OF POLY(AMINE-CO-ESTERS) AND METHODS OF USE THEREOF FOR GENE DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/332342
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 49551
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332342
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332342 | ENZYMATIC SYNTHESIS OF POLY(AMINE-CO-ESTERS) AND METHODS OF USE THEREOF FOR GENE DELIVERY | Oct 23, 2016 | Abandoned |
Array
(
[id] => 11706270
[patent_doc_number] => 20170174770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'POLYNUCLEOTIDES ENCODING RODENT ANTIBODIES WITH HUMAN IDIOTYPES AND ANIMALS COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/332583
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17921
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332583
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332583 | Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same | Oct 23, 2016 | Issued |
Array
(
[id] => 13276693
[patent_doc_number] => 10149912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Dehydrated hydrogel inclusion complex
[patent_app_type] => utility
[patent_app_number] => 15/295630
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7570
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295630 | Dehydrated hydrogel inclusion complex | Oct 16, 2016 | Issued |
Array
(
[id] => 11568865
[patent_doc_number] => 20170107510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'DNA NANOPARTICLE BASED CHECKPOINT INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/293999
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5655
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293999 | DNA NANOPARTICLE BASED CHECKPOINT INHIBITORS | Oct 13, 2016 | Abandoned |
Array
(
[id] => 11567364
[patent_doc_number] => 20170106008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES'
[patent_app_type] => utility
[patent_app_number] => 15/292434
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18393
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/292434 | STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases | Oct 12, 2016 | Issued |
Array
(
[id] => 11992511
[patent_doc_number] => 20170296665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'TARGETED NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/291485
[patent_app_country] => US
[patent_app_date] => 2016-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33548
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15291485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/291485 | Targeted nanoparticles | Oct 11, 2016 | Issued |